HR 937 · 116th Congress · Health

Right Rebate Act of 2019

Introduced 2019-01-31· Sponsored by Rep. Schrader, Kurt [D-OR-5]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.(2019-01-31)

Plain Language Summary

[AI summary unavailable — showing source text] Right Rebate Act of 2019 This bill requires drug manufacturers with Medicaid rebate agreements for covered outpatient drugs to disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly).…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (1)

1 Democrat